Suppr超能文献

用于阿尔茨海默病和血管性痴呆:文献综述。

for Alzheimer's Disease and Vascular Dementia: A Literature Review.

机构信息

Department of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.

出版信息

Curr Vasc Pharmacol. 2020;18(4):358-368. doi: 10.2174/1570161117666190710151545.

Abstract

BACKGROUND

Alzheimer's disease (AD) and vascular dementia (VaD) are major types of dementia, both of which cause heavy economic burdens for families and society. However, no currently available medicines can control dementia progression. Rhizoma coptidis, a Chinese herbal medicine, has been used for >2000 years and is now gaining attention as a potential treatment for AD and VaD.

METHODS

We reviewed the mechanisms of the active ingredients of Rhizoma coptidis and Rhizoma coptidis-containing Chinese herbal compounds in the treatment of AD and VaD. We focused on studies on ameliorating the risk factors and the pathological changes of these diseases.

RESULTS

The Rhizoma coptidis active ingredients include berberine, palmatine, coptisine, epiberberine, jatrorrhizine and protopine. The most widely studied ingredient is berberine, which has extensive therapeutic effects on the risk factors and pathogenesis of dementia. It can control blood glucose and lipid levels, regulate blood pressure, ameliorate atherosclerosis, inhibit cholinesterase activity, Aβ generation, and tau hyperphosphorylation, decrease neuroinflammation and oxidative stress and alleviate cognitive impairment. Other ingredients (such as jatrorrhizine, coptisine, epiberberine and palmatine) also regulate blood lipids and blood pressure; however, there are relatively few studies on them. Rhizoma coptidis-containing Chinese herbal compounds like Huanglian-Jie-Du-Tang, Huanglian Wendan Decoction, Banxia Xiexin Decoction and Huannao Yicong Formula have anti-inflammatory and antioxidant stress activities, regulate insulin signaling, inhibit γ-secretase activity, neuronal apoptosis, tau hyperphosphorylation, and Aβ deposition, and promote neural stem cell differentiation, thereby improving cognitive function.

CONCLUSION

The "One-Molecule, One-Target" paradigm has suffered heavy setbacks, but a "multitarget- directed ligands" strategy may be viable. Rhizoma coptidis active ingredients and Rhizoma coptidiscontaining Chinese herbal compounds have multi-aspect therapeutic effects on AD and VaD.

摘要

背景

阿尔茨海默病(AD)和血管性痴呆(VaD)是主要的痴呆类型,两者都给家庭和社会带来沉重的经济负担。然而,目前尚无药物可以控制痴呆的进展。黄连是一种中药,已有 2000 多年的应用历史,现在作为 AD 和 VaD 的潜在治疗药物受到关注。

方法

我们综述了黄连及其含药复方治疗 AD 和 VaD 的作用机制,重点关注改善这些疾病的危险因素和病理变化的研究。

结果

黄连的活性成分包括小檗碱、黄连碱、巴马汀、药根碱、吴茱萸碱和原阿片碱。研究最多的成分是小檗碱,它对痴呆的危险因素和发病机制具有广泛的治疗作用。它可以控制血糖和血脂水平,调节血压,改善动脉粥样硬化,抑制乙酰胆碱酯酶活性、Aβ生成和 tau 过度磷酸化,减少神经炎症和氧化应激,缓解认知障碍。其他成分(如吴茱萸碱、药根碱、黄连碱和巴马汀)也调节血脂和血压;但是,对它们的研究相对较少。黄连及其含药复方如黄连解毒汤、黄连温胆汤、半夏泻心汤和还脑益聪方具有抗炎和抗氧化应激作用,调节胰岛素信号,抑制γ-分泌酶活性、神经元凋亡、tau 过度磷酸化和 Aβ沉积,促进神经干细胞分化,从而改善认知功能。

结论

“一个分子,一个靶点”的范式遭受了沉重的挫折,但“多靶标导向配体”策略可能是可行的。黄连的活性成分和黄连含药复方对 AD 和 VaD 具有多方面的治疗作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验